Article successfully added.

CyFlow™ HLA-G PE

CyFlow™ HLA-G PE
Antibody: Yes
Antigen: HLA-G
Application: Flow cytometry
Clonality: monoclonal
Clone: MEM-G/9
Emission Maximum: 576 nm
Excitation Maximum: 496 nm, 565 nm
Field of Interest: MHC
Format/Fluorochrome: PE
Isotype: IgG1
Laser: Blue , Green, Yellow
Regulatory Status: RUO
Source Species: Mouse
Target Species: Human
Product number: BQ870883

For Research Use Only

$255.00 USD*

Price excludes any applicable taxes plus shipping costs

Concentration Unit mg/mL Concentration 0,1 Quantity 0.1 mg Volume 1.0 mL... more
CyFlow™ HLA-G PE
Concentration Unitmg/mL
Concentration0,1
Quantity0.1 mg
Volume1.0 mL
ImmunogenRecombinant human HLA-G refolded with β2-microglobulin and peptide
UsageThe reagent is designed for Flow Cytometry analysis. Suggested working usage is 1·µg/ml. Indicated dilution is recommended starting point for use of this product, but working concentrations should be validated by the investigator.
Storage BufferThe reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.
Specific References

| Fournel S, Huc X, Aguerre-Girr M, Solier C, Legros M, Praud-Brethenou C, Moussa M, Chaouat G, Berrebi A, Bensussan A, Lenfant F, Le Bouteiller P: Comparative reactivity of different HLA‑G monoclonal antibodies to soluble HLA‑G molecules. Tissue Antigens. 2000 Jun; 55(6):510‑8. < PMID: 10902607 > | Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Bencini E, Menicucci A, Baricordi OR: HLA‑G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol. 2002 Feb; 32(2):311‑5. < PMID: 11807769 > | Pangault C, Le Friec G, Caulet-Maugendre S, Lena H, Amiot L, Guilloux V, Onno M, Fauchet R: Lung macrophages and dendritic cells express HLA‑G molecules in pulmonarydiseases. Hum Immunol. 2002 Feb; 63(2):83‑90. < PMID: 11821155 > | Lozano JM, Gonzalez R, Kindelan JM, Rouas-Freiss N, Caballos R, Dausset J, Carosella ED, Pena J: Monocytes and T lymphocytes in HIV‑1‑positive patients express HLA‑G molecule. AIDS. 2002 Feb 15; 16(3):347‑51. < PMID: 11834945 > | Abstracts from the 3rd International Conference on HLA‑G; Paris, July 2003. Tissue Antigens. 2003; 62(4):340‑57. < Wiley j.1399-0039 > | Menier C, Saez B, Horejsi V, Martinozzi S, Krawice-Radanne I, Bruel S, Le Danff C, Reboul M, Hilgert I, Rabreau M, Larrad ML, Pla M, Carosella ED, Rouas-Freiss N: Characterization of monoclonal antibodies recognizing HLA‑G or HLA‑E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol. 2003 Mar; 64(3):315‑26. < PMID: 12590976 > | Gonen-Gross T, Achdout H, Arnon TI, Gazit R, Stern N, Horejsí V, Goldman-Wohl D, Yagel S, Mandelboim O: The CD85J/leukocyte inhibitory receptor‑1 distinguishes between conformed and beta 2‑microglobulin‑free HLA‑G molecules. J Immunol. 2005 Oct 15; 175(8):4866‑74. < PMID: 16210588 > | Lopez AS, Alegre E, LeMaoult J, Carosella E, Gonzalez A: Regulatory role of tryptophan degradation pathway in HLA‑G expression by human monocyte‑derived dendritic cells. Mol Immunol. 2006 Jul; 43(14):2151‑60. < PMID: 16490253 > | Zhao L, Teklemariam T, Hantash BM: Reassessment of HLA‑G isoform specificity of MEM‑G/9 and 4H84 monoclonal antibodies. Tissue Antigens. 2012 Sep; 80(3):231‑8. < PMID: 22738368 >